Armenia vs Kazakhstan: New cases tested for RR-/MDR-TB
Armenia
100.0%
in 2024
Kazakhstan
100.0%
in 2024
Armenia rank
1st
Kazakhstan rank
1st
New cases tested for RR-/MDR-TB over time
- Armenia
- Kazakhstan
How they compare
Armenia currently reports 100.0% against 100.0% in Kazakhstan, a difference of 0.0%.
The two have swapped places 8 times across 19 shared years of data; in 2006 it was Kazakhstan ahead.
Armenia ranks 1st and Kazakhstan ranks 1st of 192 countries.
Across the 3 decades both report, Armenia averaged higher in 1 and Kazakhstan in 2.
Head to head by decade
| Decade | Armenia | Kazakhstan | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 86.5% | 73.0% | 13.5% | Armenia |
| 2010s | 93.6% | 97.1% | 3.5% | Kazakhstan |
| 2020s | 99.8% | 100.0% | 0.2% | Kazakhstan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher new cases tested for rr-/mdr-tb, Armenia or Kazakhstan?
- Armenia, at 100.0% against 100.0% in Kazakhstan as of 2024.
- What is the difference in new cases tested for rr-/mdr-tb between Armenia and Kazakhstan?
- 0.0%, with Armenia ahead.
- How many years of comparable data are there for Armenia and Kazakhstan?
- 19 years are reported by both, from 2006 to 2024.
- How do Armenia and Kazakhstan rank globally for new cases tested for rr-/mdr-tb?
- Armenia ranks 1st and Kazakhstan ranks 1st of 192 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as New cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.